Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite demineralization refers to the process by which minerals, primarily calcium and phosphate, are lost from the hydroxyapatite crystals that constitute tooth enamel. This process is triggered by acid exposure, typically resulting from bacterial metabolism of dietary sugars or acidic food/beverages, causing a decrease in pH at the tooth surface. The resulting dissolution of hydroxyapatite leads to weakened enamel, increasing susceptibility to dental caries and erosion. While early demineralization can be reversed via remineralization processes, prolonged exposure without intervention can lead to irreversible damage.
Fluoride promotes remineralization by forming fluorapatite, which is more resistant to acid attack. ACP and CPP-ACP deliver calcium and phosphate ions to the tooth surface to facilitate remineralization. Xylitol inhibits bacterial metabolism, reducing acid production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enamel Hydroxyapatite Demineralization (N/A).